CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Vericiguat

维立西呱 杂质对照品Vericiguat Impurities

38 个杂质条目38 impurity entries

本页汇总 维立西呱 的 38 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 38 impurity reference standards of Vericiguat. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 维立西呱(Vericiguat)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesThe first validated stability-indicating HPLC/DAD method for quantitation of Vericiguat in its pharmaceutical formulation; Application to degradation kinetic studies
    Talanta · 2023 · Mustafa DM et al.  ·  PMID 37011562  ·  DOI
  2. 杂质研究Impurity studiesComprehensive study on the forced degradation impurities of vericiguat with high-resolution LC-MS/MS and 1D/2D-NMR
    Talanta · 2026 · Ding L et al.  ·  PMID 42190560  ·  DOI
  3. 杂质研究Impurity studiesDifferent spectrophotometric methods for simultaneous quantitation of Vericiguat and its alkaline degradation product: a comparative study with greenness profile assessment
    Scientific reports · 2023 · Mustafa DM et al.  ·  PMID 38155184  ·  DOI
  4. 分析方法Analytical MethodsDetermination of vericiguat in rat plasma by UPLC-MS/MS and its application to drug interaction
    Journal of chromatography. A · 2023 · Ding C et al.  ·  PMID 37741219  ·  DOI
  5. 分析方法Analytical MethodsAn Investigation of Pharmacokinetic Interaction of Vericiguat with Apigenin based on a Newly Developed Ultra-performance Liquid Chromatography-tandem Mass Spectrometry Assay
    Current medicinal chemistry · 2024 · Zhang E et al.  ·  PMID 37888816  ·  DOI

维立西呱 —— 原料药与杂质对照品Vericiguat — drug substance & impurities

共 39 个条目(含原料药本体)39 items incl. the drug substance
Vericiguat structure
原料药 APIAPI
维立西呱Vericiguat
Vericiguat
CAS No.1350653-20-1
Chemical FormulaC19H16F2N8O2
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Di-DMSO structure
—
维立西呱 双二甲亚砜Vericiguat Di-DMSO
Vericiguat Di-DMSO
CAS No.1438425-69-4
Chemical FormulaC19H16F2N8O2·2(C2H6OS)
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Impurity 1 structure
1
维立西呱杂质1Vericiguat Impurity 1
Vericiguat Impurity 1
CAS No.2112745-90-9
Chemical FormulaC25H24F2N8O8
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Impurity 2 structure
2
维立西呱杂质2Vericiguat Impurity 2
Vericiguat Impurity 2
CAS No.1361570-69-5
Chemical FormulaC19H15F2N7O2
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Impurity 3 structure
3
维立西呱杂质3Vericiguat Impurity 3
Vericiguat Impurity 3
CAS No.2247631-10-1
Chemical FormulaC19H16F2N8O2
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Impurity 4 structure
4
维立西呱杂质4Vericiguat Impurity 4
Vericiguat Impurity 4
CAS No.2247631-30-5
Chemical FormulaC20H17F2N7O2
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Impurity 5 structure
5
维立西呱杂质5Vericiguat Impurity 5
Vericiguat Impurity 5
CAS No.2755814-39-0
Chemical FormulaC18H14F2N8O
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Impurity 6 structure
6
维立西呱杂质6Vericiguat Impurity 6
Vericiguat Impurity 6
CAS No.1374344-58-7
Chemical FormulaC19H16F2N8O2
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Impurity 7 structure
7
维立西呱杂质7Vericiguat Impurity 7
Vericiguat Impurity 7
CAS No.2257494-91-8
Chemical FormulaC20H17FN8O4
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Impurity 8 structure
8
维立西呱杂质8Vericiguat Impurity 8
Vericiguat Impurity 8
CAS No.2719924-23-7
Chemical FormulaC19H18F2N8O2
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Impurity 9 structure
9
维立西呱杂质9Vericiguat Impurity 9
Vericiguat Impurity 9
CAS No.1361570-70-8
Chemical FormulaC20H17F2N7O2
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Impurity 10 structure
10
维立西呱杂质10Vericiguat Impurity 10
Vericiguat Impurity 10
CAS No.2257494-62-3
Chemical FormulaC21H18F2N8O
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Impurity 12 structure
12
维立西呱杂质12Vericiguat Impurity 12
Vericiguat Impurity 12
CAS No.625115-49-3
Chemical FormulaC20H19FN8O2
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Impurity 13 structure
13
维立西呱杂质13Vericiguat Impurity 13
Vericiguat Impurity 13
CAS No.3052969-91-9
Chemical FormulaC19H17FN8O2
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Impurity 14 structure
14
维立西呱杂质14Vericiguat Impurity 14
Vericiguat Impurity 14
CAS No.1350653-30-3
Chemical FormulaC17H14F2N8
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Impurity 15 structure
15
维立西呱杂质15Vericiguat Impurity 15
Vericiguat Impurity 15
CAS No.1188384-03-3
Chemical FormulaC2H4FNO2
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Impurity 16 structure
16
维立西呱杂质16Vericiguat Impurity 16
Vericiguat Impurity 16
CAS No.1188384-00-0
Chemical FormulaC4H8FNO2
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Impurity 30 structure
30
维立西呱杂质30Vericiguat Impurity 30
Vericiguat Impurity 30
CAS No.1361232-73-6
Chemical FormulaC14H10F2N4O
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Impurity 31 structure
31
维立西呱杂质31Vericiguat Impurity 31
Vericiguat Impurity 31
CAS No.1350653-24-5
Chemical FormulaC13H8F2IN3
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Impurity 32 structure
32
维立西呱杂质32Vericiguat Impurity 32
Vericiguat Impurity 32
CAS No.1361232-72-5
Chemical FormulaC16H13F2N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Impurity 33 structure
33
维立西呱杂质33Vericiguat Impurity 33
Vericiguat Impurity 33
CAS No.1256788-84-7
Chemical FormulaC6H4FN3
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Impurity 34 structure
34
维立西呱杂质34Vericiguat Impurity 34
Vericiguat Impurity 34
CAS No.1350653-23-4
Chemical FormulaC6H3FIN3
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Impurity 35 structure
35
维立西呱杂质35Vericiguat Impurity 35
Vericiguat Impurity 35
CAS No.2921663-98-9
Chemical FormulaC13H9F2N3
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Impurity 37 structure
37
维立西呱杂质37Vericiguat Impurity 37
Vericiguat Impurity 37
CAS No.446-51-5
Chemical FormulaC7H7FO
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Impurity 38 structure
38
维立西呱杂质38Vericiguat Impurity 38
Vericiguat Impurity 38
CAS No.2135333-04-7
Chemical FormulaC14H9F2N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Impurity 40 structure
40
维立西呱杂质40Vericiguat Impurity 40
Vericiguat Impurity 40
CAS No.1426309-48-9
Chemical FormulaC14H11F2N5·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Impurity 45 structure
45
维立西呱杂质45Vericiguat Impurity 45
Vericiguat Impurity 45
CAS No.326-62-5
Chemical FormulaC8H6FN
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Impurity 46 structure
46
维立西呱杂质46Vericiguat Impurity 46
Vericiguat Impurity 46
CAS No.459-22-3
Chemical FormulaC8H6FN
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Impurity 49 structure
49
维立西呱杂质49Vericiguat Impurity 49
Vericiguat Impurity 49
CAS No.1361570-29-7
Chemical FormulaC23H17F2N9
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Impurity 53 (Mixture of E/Z-isomers) structure
53
维立西呱杂质53 (混合E/Z构型)Vericiguat Impurity 53 (Mixture of E/Z-isomers)
Vericiguat Impurity 53 (Mixture of E/Z-isomers)
CAS No.93866-45-6
Chemical FormulaC15H10N6
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Impurity 54 structure
54
维立西呱杂质54Vericiguat Impurity 54
Vericiguat Impurity 54
CAS No.1350653-26-7
Chemical FormulaC14H8F2N4
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Impurity 55 structure
55
维立西呱杂质55Vericiguat Impurity 55
Vericiguat Impurity 55
CAS No.3036777-99-5
Chemical FormulaC13H8ClF2N3
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Impurity 58 structure
58
维立西呱杂质58Vericiguat Impurity 58
Vericiguat Impurity 58
CAS No.1034667-22-5
Chemical FormulaC6H5FN4
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Impurity 70 structure
70
维立西呱杂质70Vericiguat Impurity 70
Vericiguat Impurity 70
CAS No.4090-37-3
Chemical FormulaC9H8N4O
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Impurity 72 structure
72
维立西呱杂质72Vericiguat Impurity 72
Vericiguat Impurity 72
CAS No.907165-30-4
Chemical FormulaC9H8N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Impurity 73 structure
73
维立西呱杂质73Vericiguat Impurity 73
Vericiguat Impurity 73
CAS No.2940236-31-5
Chemical FormulaC39H32F4N16O4
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Impurity 74 structure
74
维立西呱杂质74Vericiguat Impurity 74
Vericiguat Impurity 74
CAS No.501-00-8
Chemical FormulaC8H6FN
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Impurity 77 (Mixture of E/Z-isomers) structure
77
维立西呱杂质77 (混合E/Z构型)Vericiguat Impurity 77 (Mixture of E/Z-isomers)
Vericiguat Impurity 77 (Mixture of E/Z-isomers)
CAS No.15106-70-4
Chemical FormulaC9H7N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Vericiguat Impurity 89 structure
89
维立西呱杂质89Vericiguat Impurity 89
Vericiguat Impurity 89
CAS No.2735714-59-5
Chemical FormulaC15H11F2N3O2
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

维立西呱 —— 研究文献与合成路线Vericiguat — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 维立西呱 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Vericiguat. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Comprehensive study on the forced degradation impurities of vericiguat with high-resolution LC-MS/MS and 1D/2D-NMR
    Ding L, Zhang R, Deng W, et al. · Talanta · 2026
  2. The first validated stability-indicating HPLC/DAD method for quantitation of Vericiguat in its pharmaceutical formulation; Application to degradation kinetic studies
    Mustafa DM, Magdy N, El Azab NF · Talanta · 2023 · 被引 4cited 4
  3. Different spectrophotometric methods for simultaneous quantitation of Vericiguat and its alkaline degradation product: a comparative study with greenness profile assessment
    Mustafa DM, Magdy N, El Azab NF · Scientific reports · 2023 · 被引 3cited 3

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

维立西呱 杂质谱研究要点Vericiguat — impurity profiling notes

下面这些是拿到 维立西呱 的 39 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 39 impurity entries for Vericiguat, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances